Gilles Gasser
Gilles Gasser
Chimie ParisTech, PSL University, CNRS, Institute of Chemistry of Life and Health Sciences
Verified email at - Homepage
Cited by
Cited by
Organometallic anticancer compounds
G Gasser, I Ott, N Metzler-Nolte
Journal of medicinal chemistry 54 (1), 3-25, 2010
Combination of Ru (II) complexes and light: new frontiers in cancer therapy
C Mari, V Pierroz, S Ferrari, G Gasser
Chemical Science 6 (5), 2660-2686, 2015
Critical Overview of the Use of Ru (II) Polypyridyl Complexes as Photosensitizers in One-Photon and Two-Photon Photodynamic Therapy
F Heinemann, J Karges, G Gasser
Accounts of chemical research 50 (11), 2727-2736, 2017
The potential of organometallic complexes in medicinal chemistry
G Gasser, N Metzler-Nolte
Current opinion in chemical biology 16 (1-2), 84-91, 2012
The medicinal chemistry of ferrocene and its derivatives
M Patra, G Gasser
Nature Reviews Chemistry 1 (9), 0066, 2017
Highly Charged Ruthenium (II) Polypyridyl Complexes as Lysosome‐Localized Photosensitizers for Two‐Photon Photodynamic Therapy
H Huang, B Yu, P Zhang, J Huang, Y Chen, G Gasser, L Ji, H Chao
Angewandte Chemie International Edition 54 (47), 14049-14052, 2015
Targeted photoredox catalysis in cancer cells
H Huang, S Banerjee, K Qiu, P Zhang, O Blacque, T Malcomson, ...
Nature chemistry 11 (11), 1041-1048, 2019
Molecular and cellular characterization of the biological effects of ruthenium (II) complexes incorporating 2-pyridyl-2-pyrimidine-4-carboxylic acid
V Pierroz, T Joshi, A Leonidova, C Mari, J Schur, I Ott, L Spiccia, S Ferrari, ...
Journal of the American Chemical Society 134 (50), 20376-20387, 2012
Underestimated Potential of Organometallic Rhenium Complexes as Anticancer Agents
A Leonidova, G Gasser
ACS chemical biology 9 (10), 2180-2193, 2014
Classification of Metal-Based Drugs according to Their Mechanisms of Action
E Boros, PJ Dyson, G Gasser
Chem 6 (1), 41-60, 2020
Small organometallic compounds as antibacterial agents
M Patra, G Gasser, N Metzler-Nolte
Dalton Transactions 41 (21), 6350-6358, 2012
Metal-based photosensitizers for photodynamic therapy: the future of multimodal oncology?
SA McFarland, A Mandel, R Dumoulin-White, G Gasser
Current Opinion in Chemical Biology 56, 23-27, 2020
Visible‐light‐induced annihilation of tumor cells with platinum–porphyrin conjugates
A Naik, R Rubbiani, G Gasser, B Spingler
Angewandte Chemie 126 (27), 7058-7061, 2014
Organometallic compounds: an opportunity for chemical biology?
M Patra, G Gasser
ChemBioChem 13 (9), 1232-1252, 2012
Rationally designed ruthenium complexes for 1-and 2-photon photodynamic therapy
J Karges, S Kuang, F Maschietto, O Blacque, I Ciofini, H Chao, G Gasser
Nature communications 11 (1), 3262, 2020
Monomeric and dimeric coordinatively saturated and substitutionally inert Ru (II) polypyridyl complexes as anticancer drug candidates
A Notaro, G Gasser
Chemical Society Reviews 46 (23), 7317-7337, 2017
DNA Intercalating RuII Polypyridyl Complexes as Effective Photosensitizers in Photodynamic Therapy
C Mari, V Pierroz, R Rubbiani, M Patra, J Hess, B Spingler, L Oehninger, ...
Chemistry-A European Journal 20 (44), 14421-14436, 2014
Towards cancer cell-specific phototoxic organometallic rhenium (I) complexes
A Leonidova, V Pierroz, R Rubbiani, J Heier, S Ferrari, G Gasser
Dalton Transactions 43 (11), 4287-4294, 2014
Synthesis, Characterization, and Biological Evaluation of New Ru (II) Polypyridyl Photosensitizers for Photodynamic Therapy
A Frei, R Rubbiani, S Tubafard, O Blacque, P Anstaett, A Felgenträger, ...
Journal of medicinal chemistry 57 (17), 7280-7292, 2014
A Multi‐action and Multi‐target RuII–PtIV Conjugate Combining Cancer‐Activated Chemotherapy and Photodynamic Therapy to Overcome Drug Resistant Cancers
J Karges, T Yempala, M Tharaud, D Gibson, G Gasser
Angewandte Chemie International Edition 59 (18), 7069-7075, 2020
The system can't perform the operation now. Try again later.
Articles 1–20